In a groundbreaking partnership, JACC, the flagship journal of the American College of Cardiology, and The Lancet have announced a collaboration aimed at advancing cardiovascular health on a global scale. By leveraging their combined resources, expertise, and networks, this alliance seeks to disseminate high-quality research, foster interdisciplinary collaborations, and promote cardiovascular health worldwide.
This collaboration unites JACC's prominence in cardiology with The Lancet's broad influence in general medicine. Together, they aim to enhance the strength, diversity, and quality of research published in each journal, ultimately serving authors and readers more effectively. Both journals are published by Elsevier, which facilitates a seamless manuscript transfer system for authors seeking publication in JACC and The Lancet.
As part of their collaboration, JACC and The Lancet will spearhead several initiatives to drive progress in cardiovascular health:
• Commissions on Urgent Health Topics: The journals will partner with the research and clinical community to address pressing health issues, aiming to advance clinical care and inform public policy.
• Expert Commentary and Analysis: Joint efforts will focus on expert commentary to explore the prevention and treatment of cardiovascular disease worldwide, identifying avenues for rapid progress.
This strategic partnership is poised to transform how research and practice-changing science are disseminated and applied. By highlighting evidence-based solutions for critical health issues, JACC and The Lancet aim to enhance global health outcomes. The collaboration underscores each organization's dedication to promoting cardiovascular health and improving clinical practice through high-impact research.
Authors seeking publication in either journal will benefit from the option of a seamless manuscript transfer system. This streamlined process will facilitate the submission and review of high-quality research, ensuring that significant scientific advancements reach a broader audience more efficiently.
The joint efforts of JACC and The Lancet signify a powerful commitment to addressing the most critical health challenges. By amplifying the reach and impact of their published research, the journals aim to foster a deeper understanding of cardiovascular disease and promote the application of innovative solutions to improve health outcomes worldwide.
Click here to read the original press release.
